Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

619.60INR
16 Aug 2018
Change (% chg)

-- (--)
Prev Close
Rs619.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
451,475
52-wk High
Rs621.95
52-wk Low
Rs434.80

Summary

Name Age Since Current Position

Israel Makov

78 2012 Non-Executive Chairman of the Board

C. Muralidharan

2017 Chief Financial Officer

Sunil Ajmera

2011 Compliance Officer, Company Secretary

Dilip Shanghvi

62 2012 Managing Director, Executive Director

Sailesh Desai

1999 Whole-time Director

Kalyanasundaram Subramanian

63 2017 Whole Time Director

Sudhir Valia

60 2004 Whole-time Director

Gautam Doshi

65 2018 Additional Director

Vivek Sehgal

2017 Additional Independent Director

S. Mohanchand Dadha

1997 Non-Executive Independent Director

Ashwin Dani

75 Non-Executive Independent Director

Keki Mistry

62 2002 Non-Executive Independent Director

Rekha Sethi

2015 Non-Executive Independent Director

Nimish Desai

IR Officer

Biographies

Name Description

Israel Makov

Mr. Israel Makov is Non-Executive Chairman of the Board of Sun Pharmaceutical Industries Limited., effective May 29, 2012. Mr. Makov holds a B.Sc. an Agriculture and M.Sc in Economics from the Hebrew University, Jerusalem. Mr. Makov is the former President and CEO of Teva Pharmaceutical Industries Ltd. He joined Teva in 1995 and led the company's global expansion, managing over 12 acquisition - two of which were the M&A deals in the Israeli history at the time. Prior to joining Teva in 1995, Mr. Makov led a number of companies in various industries, and founded Israel's first biotech company, Interpharm which went public in the US as the first Israeli company in R&D stage.

C. Muralidharan

Sunil Ajmera

Dilip Shanghvi

Mr. Dilip Shantilal Shanghvi is Managing Director, Executive Director of Sun Pharmaceutical Industries Limited. He resigned as Executive Chairman of the Board of the Company, effective May 28, 2012. He is a graduate from Calcutta University and has launched Sun Pharma in 1982 and carries industrial experience in the Pharmaceutical industry and at present he is the Chairman and Managing Director of the Company. His other directorships includes: Caraco Pharmaceutical Laboratories Ltd., Detroit, USA, Sun Speciality Chemicals Pvt. Ltd., Sun Resins & Polymers Pvt. Ltd., Sun Fastfin Services Pvt. Ltd., Sun Petrochemicals Private Limited, SPARC Bio-Research Private Limited, Sun Pharma Global Inc., British Virgin Island, Sun Pharma De Mexico SA DE CV, SPIL De Mexico SA DE CV and Shantilal Shanghvi Foundation.

Sailesh Desai

Mr. Sailesh T. Desai is Whole-time Director of Sun Pharmaceutical Industries Limited. He graduate from Kolkata (Calcutta) University and is an entrepreneur with more than 30 years of industrial experience including 20 years in the pharmaceutical industry itself. His other directorships includes: Caraco Pharmaceutical Laboratories Ltd., Milmet Pharma Ltd., Sun Fastfin Services Pvt. Ltd., Sun Pharmaceutical (Bangladesh) Ltd., Sun Resins & Polymers Pvt. Ltd., Sun Speciality Chemicals Pvt, Ltd., SPIL De Mexico SA DE CV, M.J. Pharmaceuticals Ltd., Man Infraconstruction Ltd., Universal Enterprises Pvt. Ltd., Shantilal Shanghvi Foundation and a trustee of Shree Uvasaggahar Trust.

Kalyanasundaram Subramanian

Mr. Kalyanasundaram Subramanian is Whole Time Director of the Company. He joined Sun Pharmaceutical Industries Limited ('Sun') in January 2010 after 22 years with GSK in various parts of the world. Mr. Kal is a Chemistry graduate and a Chartered Accountant from India with 37 years of experience of which some 30 years in the pharmaceutical industry. Mr. Kat's career in Pharma industry began when he joined Burroughs Wellcome, in New Zealand as Commercial Advisor in 1988. His long and varied career with Burroughs Wellcome in New Zealand which was acquired by Glaxo to become GlaxoWellcome and finally GlaxoSmithKline, includes assignments as Vice President, head of Classic Brands business of Emerging Markets; Area Director South Asia & Managing Director, GSK India; Managing Director - GlaxoWellcome, Singapore (Singapore, Indochina & Myanmar). Commercial Director - Burroughs Wellcome, New Zealand. In 2010, Kal joined Sun as the CEO and Director to manage India and Emerging Markets. Kal was instrumental in Merck (MSD) and Sun collaboration and spearheaded opening of Sun operations in few important markets such as Japan, MENA. In 2012, Kal moved to USA to Taro Pharmaceutical Industries Ltd. ('Taro'), a subsidiary of Sun, to assume responsibility of Taro's operations in North America. In January 2017, Kal moved back to India to manage India and EM regions of Sun. On February 13, 2017, Kal has also been appointed as the CEO & Whole-time Director of Sun Pharma Laboratories Limited, a wholly owned subsidiary of Sun.

Sudhir Valia

Mr. Sudhir V. Valia is Whole-time Director of Sun Pharmaceutical Industries Limited. He is a fellow Member of Institute of Chartered Accountants of India and carries more than two decades of taxation and finance experience. He joined the company in 1994, prior to which he was in private taxation practice. In addition to being on the Board of Directors of a number of companies in the group, he is also on the Board of Directors of Caraco.

Gautam Doshi

Shri. Gautam Bhailal Doshi is Additional Director of the Company. He is a Chartered Accountant and Masters in Comrnerce, has been in professional practice for over 40 years. He advises various industrial groups and families and also serves as director on boards of public listed and unlisted companies. Mr. Doshi has more than 40 years of experience in wide range of areas covering Mergers and Acquisitions, Direct, Indirect and International Taxation, Transfer Pricing, Accounting and Corporate and Commercial Laws. He has been actively involved in conceptualizing and implementing a number of mergers and restructuring transactions both domestic and cross border, involving many of the top 20 listed companies on the BSE as also those forming part of FTSE 100. A prolific speaker, Mr Doshi has addressed several seminars and conferences within and outside of India and courses organized by the Institute of Chartered Accountants of India, International Fiscal Association, Other professional bodies and Chambers of Commerce. He has served on the Councils of Western Region as also All India level of the Institute of Chartered Accountants of India which has the task of development and regulation of profession of accountancy in India. During his tenure on the Council, he served on several committees and contributed significantly to the work of Board of Studies which is responsible for education and system of training of students. He also served as Chairman of Committees on direct and indirect taxation.

Vivek Sehgal

S. Mohanchand Dadha

Mr. S. Mohanchand Dadha is Non-Executive Independent Director of Sun Pharmaceutical Industries Limited. He is an entrepreneur with more than five decades of wide experience in Pharma Industry and has competent knowledge and experience in financial and accounting areas, Mr. Dadha was Managing Director and Promoter of erstwhile Tamilnadu Dadha Pharmaceuticals Ltd. He is also trustee of many Charitable Trusts. He was the Member of Tamilnadu Government constituted Drug Committees, namely The Drug Advisory Committee and the Committee for the development of Drug Industries in Tamilnadu. Presently, he is also a Director in the following Companies are Sun Pharma Advanced Research Company Ltd., Wardex Pharmaceuticals Ltd., Dadha Pharma Pvt. Ltd., and Kerala Chemists and Distributors Alliance Ltd. He served as the Chairman of the Audit Committee and Remuneration Committee of Sun Pharma Advanced Research Company Ltd.

Ashwin Dani

Mr. Ashwin S. Dani is Non-Executive Independent Director of Sun Pharmaceutical Industries Limited. He is a science graduate from the Institute of Science, University of Mumbai and U.D.C.T., University of Mumbai. He also holds a Masters Degree in polymer science from University of Akron, Ohio, USA and Diploma in colour science from Rensellaer Polytechnic, Troy, New York. He is Vice Chairman and Managing Director of Asian Paints (India) Limited. He also holds a number of directorships and has been nominated by the government as a Trustee on the Central Board of Trustees of the Employees Provident Fund. He is also a member of the executive committee of the Federation of Indian Chambers of Commerce and industry.

Keki Mistry

Mr. Keki Minoo Mistry, CPA, is Non-Executive Independent Director of Sun Pharmaceutical Industries Limited. He is a Fellow Member of the Institute of Chartered Accountants of India and a Member of the Michigan Association of Certified Public Accountants, USA. He is the Managing Director of the Housing Development Finance Corporation Limited. He has worked as a consultant to the Commonwealth Development Corporation in various emerging markets as well as to the Asian Development Bank. He holds a number of directorships and is a member of the management committee of the Bombay Chamber of Commerce & Industry.

Rekha Sethi

Ms. Rekha Sethi is Non-Executive Independent Director of the company.

Nimish Desai

Basic Compensation